HER2-IN-7 structure
|
Common Name | HER2-IN-7 | ||
|---|---|---|---|---|
| CAS Number | 2387574-01-6 | Molecular Weight | 565.55 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H26F3N7O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of HER2-IN-7HER2-IN-7 is a potent inhibitor of HER2. Deregulation of ErbB family signalling modulates proliferation, invasion, metastasis, angiogenesis, and tumour cell survival. HER2-IN-7 has the potential for the research of diseases associated ErbBs (especially HER2), including cancer (extracted from patent WO2019214634A1, compound 23)[1]. |
| Name | HER2-IN-7 |
|---|
| Description | HER2-IN-7 is a potent inhibitor of HER2. Deregulation of ErbB family signalling modulates proliferation, invasion, metastasis, angiogenesis, and tumour cell survival. HER2-IN-7 has the potential for the research of diseases associated ErbBs (especially HER2), including cancer (extracted from patent WO2019214634A1, compound 23)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Zhengtao LI, et al. Erbb receptor inhibitors. Patent WO2019214634A1. |
| Molecular Formula | C28H26F3N7O3 |
|---|---|
| Molecular Weight | 565.55 |
| InChIKey | FXGTVDHLZGHHIJ-UHFFFAOYSA-N |
| SMILES | COc1ccc2ncnc(Nc3ccc(Oc4cc5ncnn5cc4F)c(C)c3)c2c1OC1CCN(C)CC1(F)F |